Loading clinical trials...
Loading clinical trials...
An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients With Moderately to Severely Active Crohn's Disease
Conditions
Interventions
Vedolizumab
Locations
69
United States
TLC Clinical Research Inc - Los Angeles
Los Angeles, California, United States
Medical University of South Carolina (MUSC)
Charleston, South Carolina, United States
Houston Methodist Hospital
Houston, Texas, United States
Concord Repatriation General Hospital
Concord, New South Wales, Australia
Mater Misericordiae Ltd
South Brisbane, Queensland, Australia
Calvary Adelaide Hospital
Adelaide, South Australia, Australia
Start Date
August 7, 2024
Primary Completion Date
January 3, 2029
Completion Date
February 6, 2029
Last Updated
January 15, 2026
NCT07245394
NCT07089420
NCT05698745
NCT06896305
NCT06651281
NCT06579443
Lead Sponsor
Alimentiv Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions